Rheumatic Fever Treatment Market is estimated with a CAGR of 5.2% during the forecast period

 


Rheumatic Fever Treatment Market is estimated with a CAGR of 5.2% during the forecast period. Rheumatic fever is an infectious inflammatory condition that can occur as a result of strep throat that hasn't been properly handled. Rheumatic fever can cause long-term damage to the heart and heart valves in some people. It develops as a result of group A streptococcal pharyngitis that takes a long time to resolve. It may affect the joints, heart, blood vessels, and skin's connective tissues. Rheumatic fever is a leading cause of death in people over the age of 50. When compared to younger people, people aged 50 and up have a higher prevalence of rheumatic disease and a higher mortality rate. Rheumatic fever is one of the most common causes of disability.

The report " Rheumatic Fever Treatment Market, By Drug Class (Antibiotics, Non-Steroidal Anti-Inflammatory Drugs, Disease Modifying Anti-Rheumatic Drugs And Anticonvulsant Medication Drugs), By Distribution Channel (Hospital Pharmacies, Online Pharmacies And Retail Pharmacies), By Route Of Administration ( Oral, Parenteral And Topical) And By Region (North America, Europe, Asia Pacific, Latin America, And Middle East & Africa) - Market Trends, Analysis, And Forecast Till 2030”

 

Key Highlights:

  • The World Health Assembly passed a resolution WHA 71.14 in 2018, urging WHO to initiate a global organised response to rheumatic heart disease and rheumatic fever.
  • The 13th WHO General Programme of Work, specifically the strategic focus on universal health coverage; access to drugs, vaccines, and health goods, makes ensuring a steady, high-quality supply of benzathine penicillin a top priority.

Analyst View:

Growing strep throat cases and the rising prevalence of rheumatic heart disease are expected to be the primary drivers of market growth over the forecast period. Over the forecast period, a lack of knowledge about rheumatic fever, especially in developing countries, is likely to be a major impediment to the global rheumatic fever market. The lack of healthcare facilities in developed countries is also a significant business constraint. Furthermore, increased government spending in the healthcare sector aids business expansion. When compared to developed countries, the incidence rate of rheumatic fever is higher in developing countries.

 Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230

 

Key Market Insights from the report:

Th Rheumatic Fever Treatment Market is estimated with a CAGR of 5.2% during the forecast period. The Rheumatic Fever Treatment Market is segmented based on the drug class, distribution channel, route of administration, end-user, and region.

  • By drug class, the Rheumatic Fever Treatment Market is segmented into Antibiotics, non-steroidal anti-inflammatory drugs, disease modifying anti-rheumatic drugs and anticonvulsant medication drugs
  • By distribution channel, the market is segmented in Hospital pharmacies, online pharmacies and retail pharmacies.
  • By route of administration, the Rheumatic Fever Treatment Market is segmented into oral, parenteral and topical.
  • By region, the Rheumatic Fever Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Due to a well-developed healthcare system, the prevalence of cardiovascular diseases, and rising healthcare expenditure, the Americas are expected to dominate the global rheumatic fever market.

Competitive Landscape:

The key players operating in the global rheumatic fever market includes Abbott, F. Hoffmann-La Roche Ltd, Novartis, Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Bayer AG, and Bausch Health Companies Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

 

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

 

 

Comments

Post a Comment

Popular posts from this blog

Patient Portal Market is estimated to be US$ 7862.01 billion by 2030 with a CAGR of 11.50% during the forecast period

Image
  Patient Portal Market  accounted for US$ 2643.21 million in 2020 and is estimated to be US$ 7862.01 million by 2030 and is anticipated to register a CAGR of 11.50%. The patients can share and view their health information and communicate remotely. These characteristics enables patients to look into various data points, such as diagnostic test results, medical history, and prescription information. Patient portal is one of the many tools that allow the healthcare payers and providers to arrive at outcomes, which are patient-centric. Rapid technological advancements in the digital space are rising the engagement level of patients in the entire healthcare ecosystem. Data points collected on a per-patient basis through patient portal can be used for performing pin-point diagnosis, designing better clinical trials, and helping in the elimination of administration of redundant therapies and drugs to individual patients. The report   "   Global Patient Portal Market, By P...
Read more

Knee Replacement Market is estimated to be 14.2 billion by 2029 with a CAGR of 4.3% during the forecasted period.

Image
  knee replacement market  accounted for 9.7 billion in 2020 and is estimated to be US$ 14.2 billion by 2029 and is anticipated to register a CAGR of 4.3%. The report " Global Knee Replacement Market, By Product ( Total Knee Replacement, Partial Knee Replacement, Kneecap Replacement, and Complex (or revision) Knee Replacement),  By End Users ( Hospitals, Orthopedic Centers, and Other ),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In March 2018, Smith and Nephew announced commercial release of bi-cruciate retaining Journey II XR total knee arthroplasty across the U.S. and Japan. The product launch was aimed at capturing large customer base with innovative product offering. In October 2018, Zimmer Biomet Holdings announced to collaborate with Apple to facilitate patient and surgeon connection during the knee and hip replacement procedures. Th...
Read more

Nuclear Medicine Market is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period

Image
  The Nuclear Medicine Market accounted for US$ 4.26 billion and is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period. Nuclear medicine may be a medicine involving the appliance of radioactive substances within the diagnosis and treatment of disease. Medicine imaging, during a sense, is "radiology done inside out" or "endoradiology" because it records radiation emitting from within the body instead of radiation that's generated by external sources like X-rays. Additionally, medicine scans differ from radiology, because the emphasis isn't on imaging anatomy, but on the function. For such reason, it's called a physiological imaging modality. Single photon emission computerized tomography (SPECT) and positron emission tomography (PET) scans are the 2 commonest imaging modalities in medicine.   The report "  Global Nuclear Medicine Market, By Diagnostics (Single Photon Emission, Computed Tomography (SPECT), an...
Read more